Analysis Chemo Pharma Laboratories Limited (CHEMOPH)
6/5/2024
Analysis of Chemo Pharma Laboratories Limited (CHEMOPH)
Chemo Pharma Laboratories Limited has shown a recent downward trend in its stock price, with the price closing at 69.00 on June 4th, 2024. The Relative Strength Index (RSI) is at 19.05, indicating an oversold condition. The Moving Average Convergence Divergence (MACD) is negative at -2.20, with the signal line below the MACD line, suggesting a bearish signal.The Simple Moving Average (SMA) is at 78.86, the Exponential Moving Average (EMA) is at 76.69, and the Weighted Moving Average (WMA) is at 77.46. All these moving averages are above the current closing price, indicating a bearish trend.
Overall, based on the technical indicators, Chemo Pharma Laboratories Limited is currently in a bearish phase, with the stock price likely to continue its downward trend in the near term. Investors may consider exercising caution or implementing risk management strategies when trading this stock.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% from the previous year's quarter. The number of analysts providing estimates remains at 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, indicating a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates has increased to 38.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates remains at 38.
Overall, the estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with a more substantial increase expected in the next fiscal year. The growing number of analysts providing estimates indicates continued interest and attention from the investment community in the company's performance.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years is 20.1%
It can be observed that the company is expected to experience a significant decrease in growth rate compared to the past 5 years, with a notable drop from 20.1% to 9.7% for the next 5 years. Additionally, the growth rates for the current and next quarter are relatively lower compared to the annual growth rates.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price both above the current price. However, there is a wide range of forecasts, from a low of $164 to a high of $275, indicating some uncertainty in the market.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has a strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has a beta of 1.264 and has shown a positive change over the past fifty-two weeks.
Valuation metrics show a relatively high PEG ratio and forward PE ratio, with the company being valued at a significant market capitalization. The price to book ratio and price to sales ratio are also on the higher side, indicating potential overvaluation.
The stock price summary includes moving averages, fifty-two week high and low prices, and beta, providing insights into the stock's performance and volatility.
Lastly, dividends and splits information shows the company's dividend history, payout ratio, and upcoming dividend dates, as well as details on past stock splits.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. The operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. The net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023.
6. The company has been able to maintain a healthy EBITDA margin, reflecting strong operational performance.
7. The company's tax expenses have also increased over the years, in line with the growth in revenue and income.
8. The basic and diluted earnings per share (EPS) have shown an upward trend, indicating improved profitability per share.
9. Overall, the financial performance of the company in terms of revenue and income has been positive and shows a growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. The current assets include cash, inventory, and accounts receivable, with cash and cash equivalents showing fluctuations over the years.
3. Non-current assets consist of investments, machinery, furniture, equipment, and other non-current assets, which have been increasing steadily.
4. Total liabilities have also been increasing, with the highest value of $302,083,000,000 in 2022.
5. Current liabilities include short-term debt, accounts payable, and other current liabilities, showing variations over the years.
6. Non-current liabilities consist of long-term debt, other non-current liabilities, and provisions, which have been on the rise.
7. Shareholders' equity has shown an increasing trend, with the highest value of $107,147,000,000 in 2018.
8. Common stock and retained earnings are the major components of shareholders' equity, with fluctuations in other shareholders' equity.
Overall, the company's financial position seems to be stable, with a consistent increase in assets and shareholders' equity over the years.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been paying a significant amount in income taxes each year, with the highest amount in 2021.
4. The end cash position has also varied, reaching its peak in 2020 and its lowest point in 2022.
5. Financing activities have had a major impact on the cash flow, with significant amounts being used for common stock repurchase and debt issuance and payments.
6. Investing activities show a mix of acquisitions, investments, and capital expenditures, with varying levels of cash flow impact each year.
7. Overall, the company's cash flow statement reflects a combination of operational stability, financial management decisions, and investment activities that have influenced its cash position over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is higher than the EPS of $1.35 from the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 for the current year.
Overall, the analysts are forecasting growth in earnings per share both in the short term and the long term, which suggests positive expectations for the company's performance.
MACD of CHEMOPH
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
